Cargando…
Focus on the potential role of ficlatuzumab in the treatment of non-small cell lung cancer
Lung cancer treatment has rapidly changed in the last few years thanks to novel insights into cancer biology. Several biomarkers and signaling pathways have been recognized as conceivable targets for treatment, and among them is the mesenchymal–epithelial transition/hepatocyte growth factor (c-MET/H...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593708/ https://www.ncbi.nlm.nih.gov/pubmed/23493885 http://dx.doi.org/10.2147/BTT.S28908 |